Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Richard Edmondson.

Newcastle AuthorsTitleYearFull text
Dr Aiste McCormick
Professor Richard Edmondson
DNA damage repair in ovarian cancer: Unlocking the heterogeneity2018
Dr Aiste McCormick
Gavin Cuthbert
Dr Rachel O'Donnell
Dr Brian Wilson
Huw Thomas
et al.
Functional characterisation of a novel ovarian cancer cell line, NUOC-12017
Professor Richard Edmondson
Dr Angelika Kaufmann
Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative2017
Dr Rachel O'Donnell
Dr Angelika Kaufmann
Dr Laura Woodhouse
Dr Aiste McCormick
Professor Richard Edmondson
et al.
Advanced Ovarian Cancer Displays Functional Intratumor Heterogeneity That Correlates to Ex Vivo Drug Sensitivity2016
Barry Dent
Laura Ogle
Dr Rachel O'Donnell
Dr Ujjal Mallick
Professor Nicola Curtin
et al.
High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers2016
Dr Rachel O'Donnell
Professor Richard Edmondson
Hormone replacement therapy after treatment for a gynaecological malignancy2016
Dr Laura Woodhouse
Professor Richard Edmondson
Ovarian Cancer2016
Maryam Zanjirband Zanjirband
Professor Richard Edmondson
Professor John Lunec
Pre-clinical efficacy and synergistic potential of the MDM2-p53 antagonists, Nutlin-3 and RG7388, as single agents in combined treatment with cisplatin in ovarian cancer2016
Dr Aiste McCormick
Professor Richard Edmondson
A functional assay to determine the nucleotide excision repair status of ovarian cancer patients2015
Dr Amir Enshaei
Professor Craig Robson
Professor Richard Edmondson
Artificial Intelligence Systems as Prognostic and Predictive Tools in Ovarian Cancer2015
Dr Aiste McCormick
Dr Sirintra Nakjang
Dr Peter Donoghue
Professor Nicola Curtin
Professor Richard Edmondson
et al.
The role of homologous recombination recovery in cisplatin and rucaparib resistance in ovarian cancer2015
Dr Angelika Kaufmann
Professor Richard Edmondson
The use of a p53 signature identifies a group of high risk endometrial cancer associated with an excellent prognosis2015
Barry Dent
Dr Rachel O'Donnell
Laura Ogle
Padmini Ramesh
Nick Hayes
et al.
Detection and characterization of circulating tumor cells by imaging flow cytometry2014
Dr Rachel O'Donnell
Professor Richard Edmondson
Gastric-type adenocarcinoma of the cervix in a patient with Lynch syndrome: A case report2014
Professor Richard Edmondson
Dr Asima Mukhopadhyay
Professor Nicola Curtin
Molecular characterization of matched ovarian ascites and tumors suggests multiple mechanisms for a homologous recombination defective phenotype2014
Dr Rachel O'Donnell
Dr Aiste McCormick
Dr Asima Mukhopadhyay
Michelle Dixon
Dr Angelika Kaufmann
et al.
The Use of Ovarian Cancer Cells from Patients Undergoing Surgery to Generate Primary Cultures Capable of Undergoing Functional Analysis2014
Dr Angelika Kaufmann
Professor Richard Edmondson
Use of Molecular Markers Improves Prognostic Stratification in High Risk Endometrial Cancer: A Transportec Collaborative Study2014
Dr Rachel O'Donnell
Laura Woodhouse
Dr Aiste McCormick
Dr Asima Mukhopadhyay
Michelle Dixon
et al.
Functional Intra-Tumour Heterogeneity in Ovarian Cancer: What is a Representative Tumour Sample?2013
Dr Aiste McCormick
Professor Richard Edmondson
Inhibiting Double Strand Break (DSB) Repair Pathways and PTEN Sensitises Ovarian Clear Cell Carcinoma (OCCC) to Cytotoxic Agents2013
Dr Aiste McCormick
Professor Nicola Curtin
Professor Richard Edmondson
Inhibition of DNA-PK Recovers HR Function and Results in Platinum Resistance in an Ovarian Cancer Cell Line Model2013
Dr Rachel O'Donnell
Barry Dent
Laura Ogle
Professor Nicola Curtin
Dr David Jamieson
et al.
The Characterisation and Functional Assessment of Epithelial Ovarian Cancer Cells Derived from Ascitic Fluid using Imagestream2013